CALITA HILL: Open Payments
NPI 1528295078 · GRAY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173 in 8 payments from 7 companies in 2025. Trend: 2023 $120 · 2024 $105 · 2025 $173
Food & beverage: $173
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Lundbeck LLC | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: CAPLYTA, REXULTI, TRELEGY ELLIPTA, Ozempic, GVOKE HYPOPEN, UBRELVY, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
